Healthcare industry

Press release - 09/04/2011

Alexander Bürkle receives award for research into DNA repair

Dr. Alexander Bürkle from the University of Konstanz was awarded the GT-Toxicology Prize by the Society of Toxicology (part of the German Society of Experimental and Clinical Pharmacoloy and Toxicology) and the journal “Toxicology” for his work on DNA repair mechanisms. Bürkle’s research centres on the enzyme poly[ADP-ribose]polymerase (PARP). The reduced activity of PARP is known to cause the incomplete or delayed repair of continuously…

Cellzome announced today that it has achieved the second milestone in its epigenetics alliance with GlaxoSmithKline. The milestone triggers a payment of an undisclosed amount from GSK and follows only two months after the first milestone was achieved.

Press release - 18/02/2009

Award is a remit for the future

BioRegio STERN Management GmbH has been honoured by the German Federal Ministry of Economics and Technology (BMWi) for its “Regenerative Biology” competence network. It came second in the “Kompetenznetz 2009” competition on “Sustainable network development”. Hartmut Schauerte, Parliamentary Secretary of State at the BMWi and the German federal government’s commissioner for small and medium-sized businesses, presented BioRegio STERN Managing…

Press release - 14/07/2009

Amedrix GmbH - Successful cell-free products

The cell biologist Dr. Thomas Graeve has founded Amedrix GmbH in Esslingen. In future, the company will develop and produce innovative, cell-free medical products based on animal collagen for the purpose of wound regeneration and the reconstruction of degenerated soft tissue, for example.

Press release - 10/09/2009

A tinkerer with a basic instinct for success

One can squeeze every drop of goodness out of a company as if it were a juicy fruit. But there is another way of doing things as practised by the businessman Klaus Haberstroh who ploughs every hard-earned euro back into his own company year after year. Although we do not make huge profits we are still able to finance our growth without external capital said the managing director of the Stockach-based measurement device company ESE.

GENOVAC GmbH has started a research project funded by the German Ministry for Business and Technology BMWi as part of the program PRO INNO II for the Development and validation of antibodies as a novel therapeutic concept to block liver infection by hepatitis C Virus.

Press release - 30/01/2011

Door opener for influenza viruses

An international group of researchers, including scientists from the University of Tübingen, has deciphered mechanisms that enable the initiation and also the inhibition of influenza virus infections. The importin alpha-7 variant plays a crucial role in the ability of influenza A viruses to infect humans.

Jakob von Engelhardt leads a new Junior Research Group, “Synaptic Communication and Neurodegeneration”, established by the German Center for NeurodegenerativeDiseases (DZNE) at the German Cancer Research Center (DKFZ) with the aim of combining the competencies of the two institutes. Research topics of the group include the cellular foundations of learning and memory as well as the molecular causes of neurodegenerative diseases.

Press release - 10/12/2012

Cocktail boosts immune cells in fighting cancer

Natural killer cells (or NK cells), as part of the body´s immune system, can effectively fight cancer. Unfortunately, they quickly lose their aggressiveness and hence are unable to reject solid tumors. Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now discovered a cocktail consisting of three different immune mediators that leaves NK killer cells active over a long period of time. In mice,…

The human olfactory system possesses a special electric amplification mechanism that enables olfactory cells to respond even to extremely weak stimuli. Scientists at Heidelberg University headed by physiologist Prof. Dr. Stephan Frings have now established how this mechanism works. Crucial is the role played by chloride ions stored in the sensory cilia of the nose. As soon as the olfactory receptors in the sensory cilia detect odorants the…

The Thurgau Biotechnology Institute BITg located in Kreuzlingen and associated with the University of Constance will receive a total of 1.98 million Swiss Francs over the next four years. Between 2004 and 2008 the BITg already received about 400000 Swiss Francs per year.

Press release - 20/06/2011

CureVac presents new data for prostate and lung cancer vaccines

CureVac GmbH presented promising new data for prostate cancer vaccine CV9103 and lung cancer vaccine CV9201 at the ASCO Conference in Chicago. Final trial results confirm safety and excellent antigen-specific immunogenicity of prostate cancer vaccine CV9103. And initial promising data from phase I/IIa trial of lung cancer vaccine CV9201 further supports the potential of CureVac’s RNActive® vaccination technology in cancer immunotherapy and…

Press release - 27/05/2014

DKFZ and NCT: individualized cancer medicine

Comprehensive genome analyses of cancer cells have shown that each tumor and cancer patient are unique and need to be treated individually. To pave the way, by 2015 the National Center for Tumor Diseases (NCT) Heidelberg aims to offer cancer patients at the NCT analyses of their individual cancer genomes to be used as the basis for personalized recommendations for treatment. This initiative from the DKFZ and NCT has been made possible by generous…

Press release - 09/02/2012

European tool enables companies to open up markets

BioRegio STERN Management GmbH is one of five project partners in BIOMAT-In. This transnational EU project promotes innovations and cooperation in the biomaterials sector and is being funded for three years with a total of EUR 1.24 million. BioRegio STERN Management GmbH is committed to creating a successful pan-European cluster in regenerative medicine and tissue engineering. It is receiving EUR 223,000 during this period to develop a…

Scientists at the University Hospital of Ulm and the Hanover Medical School MHH have succeeded in deciphering genetic defects in patients suffering from acute myeloid leukaemia. Their findings allow for more individualised therapies in the future.

The benchmark paper on the Genetic Diagnostics Act which has long been heralded by the governing coalition foresees the binding counselling of people concerned. The coalition is opposed to allowing employers to require their employees to undergo genetic tests.

Press release - 18/09/2012

CureVac Secures €80 Million in Series D Financing

CureVac GmbH, a clinical stage biopharmaceutical company developing a new class of therapies and vaccines based on mRNA, announced on september 18 the completion of an €80 million financing round with its main investor, dievini Hopp BioTech Holding. In the next years, CureVac will use the proceeds mainly to advance the development of its two lead RNActive® cancer vaccines against prostate cancer and non-small cell lung cancer (NSCLC),…

A protein which acts as a danger signal in the body causes an unknown form of cell death in malignant brain tumors. This process is characterized by the formation of giant mitochondria in the dying cells. This has been discovered by scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the Institute of Pathology of Heidelberg University. Healthy brain cells, by contrast, are resistant to this form of cell…

For 93 of Europeans preserving biodiversity is a moral obligation affecting current generations as stewards of nature. European citizens are also aware that their well-being and quality of life depend on biodiversity.

The evaluation committee of the Baden-Württemberg Ministry of Economic Affairs has heaped praise on the NMI in Reutlingen the institute has a top national and international profile and it exploits synergies in a highly efficient way.

Press release - 10/02/2008

First Baden-Württemberg university approved for embryonic stem cell research

The biochemist Prof. Marcel Leist from Constance is the first Baden-Württemberg scientist to be authorised to undertake research using embryonic stem cells. Leist is investigating the effect of drugs and chemicals on human nerve cells.

Press release - 16/11/2012

ERC Advanced Grant for immunobiologist from the University of Freiburg

Prof. Dr. Michael Reth has been awarded an Advanced Grant of the European Research Council ERC. The 2.24 million Euro award will be used to fund research over the next 5 years. The Albert-Ludwigs-University scientist wants to use this special funding to explore the nanoscale organization of proteins in biological membranes. With his nanoscale explorer program Reth and his group wish to obtain new insights into membrane processes of normal and…

Press release - 09/09/2010

C&O Pharmaceutical Technology (Holdings) Ltd., Nanjing

Headquartered in Hong Kong and listed on the Singapore Exchange since October 2005 CO Pharmaceutical Technology Holdings Limited CO is an integrated pharmaceutical group in the Peoples Republic of China. The business model spans the entire value chain in the pharmaceutical industry which includes Reasearch and Development RD manufacturing marketing and distribution of CO branded respectively third party pharmaceutical products.

Press release - 14/01/2010

Deep brain stimulation successful for treatment of severely depressive patient

A team of neurosurgeons at Heidelberg University Hospital and psychiatrists at the Central Institute of Mental Health, Mannheim have for the first time successfully treated a patient suffering from severe depression by stimulating the habenula, a tiny nerve structure in the brain. The 64-year-old woman, who had suffered from depression since age 18, could not be helped by medication or electroconvulsive therapy. Since the procedure, she is for…

CureVac GmbH, the mRNA company, today announced that the Paul-Ehrlich-Institute, the German regulatory authority for medicinal products, has approved the start of a Phase IIa trial for CV9201 to treat Non-Small Cell Lung Cancer (NSCLC).